Research Isn’t Abstract Science But a Pathway to Answers, Treatments, and Hope – ASH
American Society of Hematology shared a post on LinkedIn:
“On Rare Disease Day, let’s remember that research isn’t abstract science but a pathway to answers, treatments, and hope.
For people living with rare blood disorders, every new study, discovery, and clinical trial brings us closer to better diagnostics, safer therapies, and improved quality of life.
The ASH Research Awards Fund supports innovative research that can transform care for rare blood diseases—from early-stage ideas to breakthrough treatments.
When you give, you’re directly fueling the work that patients and families are counting on.
Your support helps to:
- Advance promising research in rare blood disorders
- Accelerate the development of new treatment options
- Bring hope to patients and families worldwide
Together, we can turn rare disease research into real-world impact for the people who need it most.”
Other posts about American Society of Hematology on Hemostasis Today.
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis
-
Mar 6, 2026, 14:56Women’s Health at the Center of the 2025–2027 Global Public Affairs Agenda – ISTH
-
Mar 6, 2026, 14:44Haroun Gajraj: A Must-Have Atlas for Venous Duplex and Phlebology